Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the stock offering. Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) has priced…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now